A study on the microbial quality of sealed products for feminine hygiene


microbial quality
feminine hygiene


Introduction. Sanitary tampons have been in existence for over 60 years. Their use may present certain health risks, potentially associated with an abnormal change of microbial flora in the vagina (e.g., toxic shock syndrome). Tampon production and marketing are regulated differently in different countries. In Australia, Canada and the USA, tampons are classified as Class-II medical devices and their marketing requires pre-clinical and clinical studies, including microbiological trials. In Europe, tampons are considered consumer products and safety-related data are provided only if the manufacturer deems them to be useful. Sterility of these products is not requested by law; thus they may represent a potential vehicle for microorganisms.

Due to the lack of data on microbial characteristics of tampons, an analytical investigation was carried out to characterize and quantify the microbial flora present on sealed tampons of various brands present on the market in Italy.

Methods. Traditional cultural methods were used to characterize and quantify bacteria and fungi. Identification of colonies was performed with biochemical techniques.

Results. Results showed low microbial concentrations in 93% of the positive samples. A rare presence of opportunistic pathogens was detected and a few samples (6%) were characterized by bacterial species of human origin.

Conclusions. In the light of these data, the examined tampons were found to have good hygienic quality; nevertheless, to minimize the microbial risks linked to the use of these products, strict hygienic rules during their production and manipulation have to be adopted.


The Absorbent Hygiene Products Manufacturers Committee of EDANA. Sustainability Report 2007-2008. Absorbent Hygiene Products. Brussels, EDANA (International Association serving the Nonwovens and Related Industries). Available at: https://www.edana.org/docs/default-source/default-document-library/sustainability-report-2007-2008-absorbent-hygiene-products.

Medicitalia. Secchezza vaginale: domande e risposte. Available at: http://www.medicitalia.it/minforma/ginecologia-e-ostetricia/1504-secchezza-vaginale-domande-risposte.html.

Centers for Disease Control and Prevention. Toxic shock syndrome (other than Streptococcal) (TSS): 2011 Case Definition. 2014. Available at: http://wwwn.cdc.gov/nndss/script/casedef.aspx?CondYrID=869&DatePub=1/1/2011%2012:00:00%20AM.

Ross RA, Onderdonk AB. Production of toxic shock syndrome Toxin 1 by Staphylococcus aureus requires both oxygen and carbon dioxide. Infect Immun. 2000;68(9):5205-9. doi:10.1128/IAI.68.9.5205-5209.2000.

Lanes SF, Rothman KJ. Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome. J Clin Epidemiol. 1990;43(12):1379–85. https://doi.org/10.1016/0895-4356(90)90105-X.

MSD Italia. Sindrome dello shock tossico. Available at: http://www.msd-italia.it/altre/manuale/sez13/1571238.html.

Schlievert PM, Tripp TJ, Peterson ML. Reemergence of staphylococcal toxic shock syndrome in Minneapolis-St. Paul, Minnesota, during the 2000-2003 surveillance period. J Clin Microbiol. 2004;42:2875-6. doi:10.1128/JCM.43.4.2032–3.2005.

Jorup-Rönström C, Hofling M, Lundberg C, Holm S. Streptococcal toxic shock syndrome in a postpartum woman. Case report and review of the literature. Infection. 1996;24(2):164-7. doi:10.1007/BF01713330.

Tierno PM. Reemergence of Staphylococcal Toxic Shock Syndrome in the United States since 2000. J Clin Microbiol. 2005;43(4):2032–3. doi: 10.1128/JCM.43.4.2032-2033.2005.

Tierno PM. Cellulase activity of microorganisms on carboxymethylcellulose from tampons. Lancet. 1981;2(8249):746-7. doi.org/10.1016/S0140-6736(81)91066-7.

Minister of Health, Canada. Menstrual Tampons. January 2011, Catalogue: H13-7/74-2010E-PDF ISBN: 978-1-100-14914-1.

FDA. Guidance for Industry and FDA Staff Menstrual Tampons and Tampons: Information for Premarket Notification Submissions (510(k)s). 2005. Available at: http://www.fda.gov/cdrh/ode/guidance/166.pdf.

European Commission on Consumer Affairs. 2002. General product safety directive. Available at: http://ec.europa.eu/comm/consumers/cons_safe/prod_safe/gpsd/currentGPSD_en.htm.

European Disposables and Nonwovens Association (EDANA). 1999. Code of practice for tampons, version 1. Available at: http://www.edana.org.

Codice del Consumo. Dlgs 205/2006. Aggiornato al 13 giugno 2014. Available at: http://www.aduc.it/generale/files/allegati/codiceconsumo.pdf.

Chase DJ, Schenkel BP, Fahr AM, Eigner U and for the Tampon Study Group. Randomized, double-blind crossover study of vaginal microflora and epithelium in women using a tampon with a “winged” apertured film cover and a commercial tampon with a nonwoven fleece cover. American Society for Microbiology for the Tampon Study Group. J Clin Microbiol 2010;48(4):1317-22. doi: 10.1128/JCM.00359-09.

Shehin SE, Jones MB, Hochwalt AE, Sarbaugh FC, Nunn S. Clinical safety-in-use study of a new tampon design. Infect Dis Obstet Gynecol. 2003;11:89-99. https://dx.doi.org/10.1080%2F10647440300025504.

Reingold AL. Toxic shock syndrome: an update. Am J Obstet Gynecol. 1991;165(4 Pt 2):1236-9. https://doi.org/10.1016/0002-9378(12)90734-6.

Ozkocaman V, Ozcelik T, Ali R, Ozkalemkas F, Ozkan A, Ozakin C, Akalin H, Ursavas A, Coskun F, Ener B, Tunali A. Bacillus spp. among hospitalized patients with haematological malignancies: clinical features, epidemics and outcomes. J Hosp Infect. 2006;64(2):169-76. https://doi.org/10.1016/j.jhin.2006.05.014.

Vuong C, Otto M. Staphylococcus epidermidis infections. Microbes Infect 2002; 4(4):481-9. doi: 10.12691/ajidm-3-3-2.

MadSci Network. What are the effects of Micrococcus luteus on the human body? Available at: http://www.madsci.org/posts/archives/nov99/943409064.Mi.r.html.